SC 13G
SC 13G
- Company
- ImmunityBio, Inc.
- Filed
- February 12, 2016
- Accession Number
- 0001193125-16-461544
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →